Pathophysiological mechanisms in detrusor underactivity: Novel experimental findings.


Journal

Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777

Informations de publication

Date de publication:
May 2019
Historique:
received: 29 08 2018
revised: 29 11 2018
accepted: 07 01 2019
pubmed: 14 3 2019
medline: 18 12 2019
entrez: 14 3 2019
Statut: ppublish

Résumé

Underactive bladder (UAB) is a multifactorial symptom complex often related to detrusor underactivity (DU). Although recognized as a common cause of lower urinary tract symptoms and with significant effects on quality of life, UAB/DU is largely underresearched. Herein, we review up-to-date knowledge on the pathophysiological mechanisms of UAB/DU, with an emphasis on the relationship between UAB and bladder outlet obstruction (BOO). Original articles and reviews concerning UAB/DU were identified through a search of the PubMed/Medline and Scopus databases. DU can result from several pathological mechanisms, which can be categorized as idiopathic, neurogenic, myogenic, or functional. The main etiological factors of UAB/DU are aging, diabetes mellitus, neurogenic disorders, and BOO. Although conventional models focus primarily on efferent nerve and myogenic mechanisms, contemporary views highlight the importance of the afferent pathway. Specifically, recent findings in BOO showed that afferent dysfunction, such as altered expression of muscarinic and purinergic P2X

Identifiants

pubmed: 30864243
doi: 10.1111/luts.12257
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-98

Informations de copyright

© 2019 John Wiley & Sons Australia, Ltd.

Auteurs

Luís Vale (L)

Faculty of Medicine, University of Porto, Department of Urology, Hospital São João, Porto, Portugal.

Filipa Jesus (F)

Faculty of Medicine, University of Porto, Department of Urology, Hospital São João, Porto, Portugal.

Tom Marcelissen (T)

Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Malte Rieken (M)

Department of Urology, Medical University of Vienna, Vienna, Austria.

Bogdan Geavlete (B)

Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.

Mohammad Sajjad Rahnama'i (MS)

Department of Urology, Maastricht University, Maastricht, The Netherlands.
Department of Urology, Uniklinik Aachen RWTH, Aachen, Germany.

Frank Martens (F)

Department of Urology, Rabdoud University Medical Centre, Nijmegen, The Netherlands.

Francisco Cruz (F)

Faculty of Medicine, University of Porto, Department of Urology, Hospital São João, Porto, Portugal.

Tiago Antunes-Lopes (T)

Faculty of Medicine, University of Porto, Department of Urology, Hospital São João, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH